Zhejiang Taimei Medical Technology Co., Ltd. (TAIMEI TECH) disclosed a share repurchase on 14 July 2026, acquiring 46,200 H-shares on the Hong Kong Stock Exchange.

The shares were bought at prices ranging from HKD 5.90 to HKD 6.28, with a volume-weighted average cost of HKD 6.17 per share. The transaction totalled approximately HKD 0.29 million.

Key post-transaction figures: • Issued shares (excluding treasury): reduced to 197.66 million, down 0.02%. • Treasury shares: increased to 2.94 million. • Total issued shares (including treasury): unchanged at 200.59 million.

Repurchase authorisation and headroom: • Current mandate (approved 23 June 2026) permits up to 20.02 million shares to be bought back. • Aggregate repurchases under this mandate now stand at 2.52 million shares, representing 1.26% of the issued share count on the mandate date. • A 30-day moratorium on new share issues or treasury share disposals remains in place until 13 August 2026, in line with Hong Kong Listing Rules.

TAIMEI TECH confirmed all buybacks complied with Main Board Rule 10.06(4)(a) and that no material changes have been made to the previously filed explanatory statement.